InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,562.05
(
0.96%
)
US TECH 100
19,824.40
(
0.93%
)
Dow Jones
39,362.91
(
0.14%
)
Brent Oil
86.44
(
-1.02%
)
Bitcoin
56,521.48
(
-0.81%
)
Post# of 364540
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

nlightn

Send PM Follow Ignore
Followers 137
Posts 41656
Boards Moderated 7
Alias Born 01/05/2004

nlightn

Re: nlightn post# 216035

Monday, 10/06/2014 11:33:59 PM

Monday, October 06, 2014 11:33:59 PM

Post# of 364540
$REGN,...FDA approves Eylea label expansion

The FDA approves Regeneron Pharmaceuticals' (REGN -0.7%) Eylea (aflibercept) for the treatment of macular edema following retinal vein occlusion.

It was previously cleared for the treatment of neovascular age-related macular degeneration, macular edema following central retinal vein occlusion and for diabetic macular edema

invest at your own risk, based on your own due diligence, at your own risk tolerance

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up